Back to O& Oppenheimer & Co Inc

ADMA

Showing 8 of 21 quarters

Position history for O&Oppenheimer & Co Inc's holdings in ADMA Biologics Inc

Yes. Oppenheimer holds 54,480 shares of ADMA (ADMA Biologics), worth $546,434, as of its Q3 2026 13F filing. It reduced the position by 2,318 shares (-4.1%) from Q2 2026. Oppenheimer has held ADMA since Q1 2026, across 3 quarterly 13F filings.

Current Value

$546,434

Current Shares

54,480

Total Value Change

-$112,400

Total Shares Change

+16,064

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
54,480
-4.1%
$546,4340.0%$10.03
0
2026-Q2
Decreased
56,798
-7.0%
$475,3990.0%$8.37
0
2026-Q1
New
61,070
-
$550,2410.0%$9.01
34
2025-Q4
Exited
0
-100.0%
$00.0%$18.24
0
2025-Q3
Increased
49,230
+1.7%
$721,7120.0%$14.66
25
2025-Q2
Decreased
48,395
-12.5%
$881,2730.0%$18.21
0
2025-Q1
Increased
55,287
+43.9%
$1.1M0.0%$19.84
34
2024-Q4
Decreased
38,416
-59.5%
$658,8340.0%$17.15
0

Other major holders of ADMA: BlackRock, Inc.

Optional analytics helps us improve. How it’s used